Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.35B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$556M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$488M |
| 5 |
Coca-Cola
KO
|
+$464M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Microsoft
MSFT
|
+$777M |
| 4 |
McDonald's
MCD
|
+$585M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$549M |
Sector Composition
| 1 | Technology | 16.54% |
| 2 | Healthcare | 16.17% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 10.91% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
iShares US Healthcare ETF
IYH
$2.74B
| $3.77M | ﹤0.01% |
61,558
+10,267
| +20% | +$629K |
|
1827
Ecopetrol
EC
$18.3B
| $3.75M | ﹤0.01% |
335,312
+226,423
| +208% | +$2.53M |
|
1828
Genius Sports
GENI
$3.05B
| $3.75M | ﹤0.01% |
687,853
+480,068
| +231% | +$2.62M |
|
1829
Petrobras Class A
PBR.A
$75.3B
| $3.74M | ﹤0.01% |
274,122
-188,088
| -41% | -$2.57M |
|
1830
Helix Energy Solutions
HLX
$914M
| $3.74M | ﹤0.01% |
312,936
+297,496
| +1,927% | +$3.55M |
|
1831
Worthington Steel
WS
$1.71B
| $3.73M | ﹤0.01% |
111,950
+42,260
| +61% | +$1.41M |
|
1832
VanEck Steel ETF
SLX
$84.7M
| $3.73M | ﹤0.01% |
56,035
+31,290
| +126% | +$2.08M |
|
1833
Life Time Group Holdings
LTH
$6.12B
| $3.73M | ﹤0.01% |
198,064
+49,360
| +33% | +$929K |
|
1834
Monte Rosa Therapeutics
GLUE
$391M
| $3.72M | ﹤0.01% |
995,943
+15,704
| +2% | +$58.7K |
|
1835
Dynavax Technologies
DVAX
$1.14B
| $3.72M | ﹤0.01% |
331,374
+228,467
| +222% | +$2.57M |
|
1836
Goldman Sachs MarketBeta Emerging Markets Equity ETF
GSEE
$127M
| $3.71M | ﹤0.01% |
82,574
+33,856
| +69% | +$1.52M |
|
1837
iShares National Muni Bond ETF
MUB
$39.8B
| $3.71M | ﹤0.01% |
+34,844
| New | +$3.71M |
|
1838
Avantis International Large Cap Value ETF
AVIV
$846M
| $3.71M | ﹤0.01% |
70,658
+49,836
| +239% | +$2.61M |
|
|
BCYC
1839
Bicycle Therapeutics
BCYC
$480M
| $3.69M | ﹤0.01% |
182,315
+122,875
| +207% | +$2.49M |
|
|
SWTX
1840
DELISTED
SpringWorks Therapeutics
SWTX
| $3.69M | ﹤0.01% |
97,951
-612,316
| -86% | -$23.1M |
|
1841
Schwab 5-10 Year Corporate Bond ETF
SCHI
$9.17B
| $3.69M | ﹤0.01% |
167,334
+116,582
| +230% | +$2.57M |
|
1842
Gossamer Bio
GOSS
$694M
| $3.69M | ﹤0.01% |
4,093,836
+219,110
| +6% | +$197K |
|
1843
Virtus Investment Partners
VRTS
$1.29B
| $3.68M | ﹤0.01% |
16,273
+3,916
| +32% | +$884K |
|
1844
Lakeland Financial Corp
LKFN
$1.67B
| $3.67M | ﹤0.01% |
59,702
+45,478
| +320% | +$2.8M |
|
1845
Vanguard Industrials ETF
VIS
$6.26B
| $3.67M | ﹤0.01% |
15,611
+12,713
| +439% | +$2.99M |
|
1846
iShares Latin America 40 ETF
ILF
$1.88B
| $3.67M | ﹤0.01% |
148,202
+44,893
| +43% | +$1.11M |
|
1847
Ericsson
ERIC
$26.9B
| $3.66M | ﹤0.01% |
593,183
+31,875
| +6% | +$197K |
|
1848
BlueLinx
BXC
$599M
| $3.66M | ﹤0.01% |
39,297
-8,626
| -18% | -$803K |
|
|
PDCO
1849
DELISTED
Patterson Companies, Inc.
PDCO
| $3.66M | ﹤0.01% |
151,607
-322,348
| -68% | -$7.78M |
|
1850
Fulgent Genetics
FLGT
$683M
| $3.65M | ﹤0.01% |
186,235
+73,796
| +66% | +$1.45M |
|